Status:

TERMINATED

A Clinical Study of An Antimicrobial Gauze Dressing

Lead Sponsor:

Tyco Healthcare Group

Conditions:

Wounds

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine if a new antimicrobial gauze dressing is better than the current method of dressing open wounds with plain sterile gauze. It is hoped that the antimicrobial g...

Detailed Description

Without adequate debridement, chronically infected wounds persist and form a nidus for the acquisition of antimicrobial-resistant microorganisms. Multiple studies state that patients with chronic woun...

Eligibility Criteria

Inclusion

  • The subject is receiving care at the study wound care clinics.
  • The subject is 18 years of age or older.
  • The subject or authorized representative has signed the Informed Consent form.
  • The subject has a chronic wound as a result of pressure ulceration (grade III and IV ulcers only), underlying vascular disease ("leg ulcer"), diabetes mellitus (grade 2 and 3 ulcers only), or recent surgery.

Exclusion

  • The subject has a chronic ulcer that is a result of a condition other than that defined in the inclusion criteria.
  • The subject has stage I and II pressure ulceration.
  • The subject has a superficial (grade 0 or 1) or limb-threatening diabetic foot ulceration (grade 4 or 5).
  • The subject has a leg ulcer related to carcinoma.
  • The subject is scheduled to go for amputation or surgical flap procedure as a result of an open wound.
  • Subject is scheduled to receive a V.A.C.® (Vacuum Assisted Closure) Dressing \[V.A.C.® (Vacuum Assisted Closure) Dressing KCI, Kinetic Concepts, Inc., San Antonio, TX\].
  • The subject has extensive burns or another acute diffuse skin condition (Stevens-Johnson Syndrome).
  • The subject has a history of hypersensitivity to Chlorhexidine Gluconate (CHG) or Polyhexamethylene Biguanide (PHMB).
  • The subject has severe systemic infection characterized by the systemic inflammatory response syndrome.
  • The subject has taken part in a wound healing study within the past month.
  • The subject has suspected or confirmed underlying osteomyelitis contiguous to the ulcer and is not receiving systemic antimicrobial therapy.

Key Trial Info

Start Date :

June 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2007

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00203489

Start Date

June 1 2005

End Date

August 1 2007

Last Update

November 19 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sunnybrook & Women's College Health Sciences Centre

Toronto, Ontario, Canada, M5S 1B2